We are live on ! Find out more
EDSA icon

Edesa Biotech

15 hedge funds and large institutions have $279K invested in Edesa Biotech in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

36% more funds holding

Funds holding: 1115 (+4)

36% less capital invested

Capital invested by funds: $437K → $279K (-$158K)

Holders
15
Holders Change
+4
Holders Change %
+36.36%
% of All Funds
0.4%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
1
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

EDSA Hedge Fund Activity: Q1 2016 in Review

15 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q1 2016, worth a combined $279K — down 36% from $437K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new EDSA positions and 2 closed out — a net gain of 4 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Tower Research Capital (TRC), opening a new position worth an estimated $8.75K. The largest seller was Spark Investment Management, exiting entirely with an estimated $96K sold.

  • 15 institutional investors held Edesa Biotech (EDSA) as of Q1 2016, up from 11 in Q4 2015.
  • Funds reported $279K of Edesa Biotech stock for Q1 2016, down 36% quarter-over-quarter.
  • 6 funds opened new Edesa Biotech positions in Q1 2016 and 2 closed out, a net change of +4 holders.
  • The largest Edesa Biotech buyer in Q1 2016 was Tower Research Capital (TRC), an estimated $8.75K added.
  • The largest Edesa Biotech seller in Q1 2016 was Spark Investment Management, an estimated $96K sold.

Based on aggregated 13F filings for Q1 2016.